Health & Science Reporting

China targets 2030 for BCI leadership, backed by a $165M fund and new 2026 medical standards to challenge Neuralink in the neural tech race.

Investigative reports reveal a surge in botched surgeries linked to AI malfunctions, sparking new FDA regulatory scrutiny and widespread device recalls.

Gates Foundation and OpenAI launch an AI healthcare programme in Africa, prompting scrutiny around oversight, ethics, and deployment in fragile health systems.

Discovery Health has reversed its stance and will absorb the cost of a claims processing error after public backlash from affected medical scheme members.

Doctors from Scotland and the US performed the first transatlantic robotic stroke surgery, proving AI and real-time tech can transform global healthcare.

Roche’s Elecsys pTau181 test marks a breakthrough in Alzheimer’s detection, offering a simple blood test for early diagnosis now approved in the US and Europe.

Discovery Health’s new sleep rewards promise wellness and lower premiums but critics warn of privacy risks, inequality, and health data overreach.

Chipiron is disrupting medical imaging with scalable, ultra-low field MRI technology powered by AI. Affordable, portable, and set for FDA approval by 2028.

UCL researchers uncover a new way to slow glioblastoma growth by targeting brain proteins, offering hope for future brain cancer treatments.

A breakthrough in wearable medical technology is changing the future of Parkinson’s care, one life at a time. Highlighting the transformative power of innovation in...

OpenAI scraps ChatGPT’s share-to-search feature after privacy concerns emerge over Google-indexed conversations. Here's what went wrong.

Paradromics enters the brain-computer interface race with its first human implant test, rivaling Neuralink in the quest to restore communication via BCI.

Craif raises $22M to expand its AI-powered, urine-based early cancer detection tool, miSignal, into the U.S. market, aiming for simpler screenings.

Discover how scientists are using CRISPR and stem cells to reprogram brain immune cells, offering new hope for the 55M+ people affected by Alzheimer’s.